Siena, Italy

Salvatore Oliviero

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Vegenics Pty Limited. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Salvatore Oliviero. Retrieved from https://idiyas.com/inventor/salvatore-oliviero

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Salvatore Oliviero: Inventor in Siena

Introduction

Salvatore Oliviero is an inventor associated with Siena, Italy. His patent work concerns a nucleotide molecule encoding a protein linked to the Fos-regulated gene family.

Latest Patents

Oliviero is associated with 1 patent: “C-Fos Induced Growth Factor (FIGF) and DNA Encoding Same.” The patent describes nucleotide molecules encoding a protein produced by a Fos-regulated gene, or a fragment of that protein. It also covers specified nucleotide sequences and their allelic and species variants.

Career Highlights

Oliviero’s listed professional affiliations include Vegenics Pty Limited and the University of Siena (Università degli Studi di Siena). His patent reflects work involving genetic sequences and protein encoding.

Collaborations

His affiliations connect his work with both a biotechnology company and a university. The available information does not specify particular co-inventors or the nature of his collaborations.

Conclusion

Salvatore Oliviero’s recorded invention focuses on DNA sequences encoding a Fos-regulated protein, and his listed affiliations span biotechnology and academic research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…